Capital City Bank Group reports third quarter 2026 net income of $16.9 million, reflecting quarterly growth and improved ...
Aclarion reports 85% scan volume growth in Q3 2026, expanding the CLARITY trial and securing funding through mid-2027.
Visara secures option to develop YOL104-2, a potential treatment for ocular surface squamous neoplasia, enhancing its ...
Chicago Atlantic Real Estate Finance will release Q3 2026 results on November 10, 2026, with a conference call at 9:00 a.m.
YYForce Inc. has acquired 20 wearable data collection systems, enhancing its capabilities in humanoid robotics development.
VEON Ltd. cancels 1.5% of issued shares as part of its ongoing buyback program announced in September 2026.
The company raised its full-year 2026 outlook for adjusted sales, adjusted EPS and free cash flow. RTX reported a $340 ...
Alvotech announced FDA approval for a new manufacturing process, dubbed Process 2.0, for its biosimilar SIMLANDI® (adalimumab ...
Zhihu Inc., a prominent online content community in China, announced that its ordinary resolution concerning its investment ...
Hesai Group will release Q3 2026 financial results on November 10, 2026, with a conference call at 7:00 AM ET.
Alvotech received FDA approval for a new manufacturing process for its biosimilar SIMLANDI® (adalimumab-ryvk). The new ...
$150,000 of BEST BUY CO INC lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results